18-Mar-2022 to 07:53

Drug shortage hits Zambia’s public hospitals

APA-Lusaka (Zambia) — Zambia’s public hospitals have been hit by a critical shortage of essential drugs and other medical supplies which the government has blamed on an “overhaul of the drug procurement system”.

Read more

17-Mar-2022 to 12:58

Nigeria & WHO: Partnering to contain Lassa fever

APA-Lagos (Nigeria) — “Contracting Lassa fever was a very bad experience”, says 41-year-old Marian Oyinbor, a resident of Ekpoma, Esan West Local Government Area (LGA), Edo state, who was treated for Lassa Fever – a haemorrhagic disease which has killed 98 people in Nigeria in 2022.

Read more

08-Mar-2022 to 14:58

Abidjan airport eases anti-Covid measures

APA - Abidjan (Cote d’Ivoire) — The Ivorian government is easing health controls at Abidjan airport in view of the “moderate circulation” of Covid-19 and the validity of PCR (Polymerase Chain Reaction) test results has been extended from 48 to 72 hours.

Read more

08-Mar-2022 to 08:28

Kenya signs $500m manufacturing deal with Moderna

APA -Kigali (Rwanda) — President Uhuru Kenyatta of Kenya on Monday witnessed the signing of a memorandum of understanding between Kenya and Moderna to establish the first mRNA manufacturing facility in Africa.

Read more

04-Mar-2022 to 07:17

UN embarks on polio mass vaccination exercise in Malawi

APA-Lilongwe (Malawi) — The United Nations plans to vaccinate about 2.9 million children in Malawi against polio after the southern African country declared an outbreak of the disease last month.

Read more

25-Feb-2022 to 14:16

Kenya: Renewed optimism in fight against cancer

APA-Naivasha (Kenya) — Stakeholders in the fight against cancer in Kenya remain upbeat that the country is on the right trajectory amid enhanced efforts to address the health challenge.

Read more

19-Jan-2022 to 12:21

Ramaphosa launches Africa vaccine manufacturing facility

APA-Cape Town (South Africa) — President Cyril Ramaphosa on Wednesday launched a manufacturing facility aimed at building Africa's capacity to develop COVID-19 and other vaccines as well as strengthen the continent's overall pharmaceutical footprint in a sector dominated by players from developed countries.

Read more